Boston Scientific Stents Again Beat J&J Infringement Claims
A Delaware federal judge ruled Monday that Boston Scientific Corp.'s drug-eluting Promus stents don't infringe three patents held by Johnson & Johnson subsidiary Cordis Corp., the latest victory for Boston Scientific...To view the full article, register now.
Already a subscriber? Click here to view full article